pAd388-BPTF-sh28 Citations (2)
Originally described in: BPTF inhibits NK cell activity and the abundance of natural cytotoxicity receptor co-ligands.Mayes K, Elsayed Z, Alhazmi A, Waters M, Alkhatib SG, Roberts M, Song C, Peterson K, Chan V, Ailaney N, Malapati P, Blevins T, Lisnic B, Dumur CI, Landry JW Oncotarget. 2017 May 12;8(38):64344-64357. doi: 10.18632/oncotarget.17834. eCollection 2017 Sep 8. PubMed Journal
Articles Citing pAd388-BPTF-sh28
| Articles |
|---|
| Delete_BPTF inhibits NK cell activity and the abundance of natural cytotoxicity receptor co-ligands. Mayes K, Elsayed Z, Alhazmi A, Waters M, Alkhatib SG, Roberts M, Song C, Peterson K, Chan V, Ailaney N, Malapati P, Blevins T, LisniA B, Dumur CI, Landry JW. Oncotarget. 2017 May 12. doi: 10.18632/oncotarget.17834. PubMed |
| Delete_BPTF inhibits NK cell activity and the abundance of natural cytotoxicity receptor co-ligands. Mayes K, Elsayed Z, Alhazmi A, Waters M, Alkhatib SG, Roberts M, Song C, Peterson K, Chan V, Ailaney N, Malapati P, Blevins T, Lisnic B, Dumur CI, Landry JW. Oncotarget. 2017 May 12;8(38):64344-64357. doi: 10.18632/oncotarget.17834. eCollection 2017 Sep 8. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.